Affordable Access

Publisher Website

Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.

Authors
Type
Published Article
Journal
Diabetes Technology & Therapeutics
1557-8593
Publisher
Mary Ann Liebert
Publication Date
Volume
15
Issue
4
Pages
335–341
Identifiers
DOI: 10.1089/dia.2012.0287
PMID: 23480592
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments